General
The Molecular Diagnostic Services Program (MolDX) was developed to identify and establish coverage and reimbursement for molecular diagnostic tests. MolDX success hinges on three components: Test registration and ID assignment, application review, and coverage determination and reimbursement.
M00118, V2
General Articles
MolDX ManualClaim InquiriesMulti-Jurisdictional MolDX: Predictive Testing to Guide Targeted Therapy Selection in Rheumatoid Arthritis Contractor Advisory Committee (CAC): December 7, 2021Enforcement Delay - MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing L38988MolDX Open Meeting: May 10, 2022MoIDX Open Meeting: August 1, 2022